Clinical Implementation
RecovryAI receives first-known FDA Breakthrough Device Designation for patient-facing generative AI, establishing new regulatory precedent for clinical AI responsibility.
New comprehensive review maps the landscape of AI applications in trauma care while highlighting critical ethical and implementation challenges that must be addressed for responsible clinical integration.